investorscraft@gmail.com

Intrinsic Value of Natus Medical Incorporated (NTUS)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %13.9NaN
Revenue, $473NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m450NaN
Operating income, $m24NaN
EBITDA, $m52NaN
Interest expense (income), $mNaN
Earnings before tax, $m19NaN
Tax expense, $m6NaN
Net income, $m13NaN

BALANCE SHEET

Cash and short-term investments, $m76NaN
Total assets, $m564NaN
Adjusted assets (=assets-cash), $m489NaN
Average production assets, $m252NaN
Working capital, $m163NaN
Total debt, $m12NaN
Total liabilities, $m140NaN
Total equity, $m425NaN
Debt-to-equity ratio0.028NaN
Adjusted equity ratio0.725NaN

CASH FLOW

Net income, $m13NaN
Depreciation, amort., depletion, $m28NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m64NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1NaN
Free cash flow, $m65NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m163
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount